California picks Utah-based generic drug company Civica to produce low-cost insulin
The move puts the state government in direct competition with the brand-name drug companies that dominate the market.
(DigitalVision | Getty Images) Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California.
Donate to the newsroom now. The Salt Lake Tribune, Inc. is a 501(c)(3) public charity and contributions are tax deductible